pSG5-P190 Citations (5)
Originally described in: Bcr/Abl P190 interaction with Spa-1, a GTPase activating protein for the small GTPase Rap1.Yi SJ, Lee HT, Groffen J, Heisterkamp N Int J Mol Med. 2008 Oct . 22(4):453-8. PubMed
Articles Citing pSG5-P190
| Articles |
|---|
| Mcl-1 downregulation leads to the heightened sensitivity exhibited by BCR-ABL positive ALL to induction of energy and ER-stress. Leclerc GJ, DeSalvo J, Du J, Gao N, Leclerc GM, Lehrman MA, Lampidis TJ, Barredo JC. Leuk Res. 2015 Aug 20. pii: S0145-2126(15)30360-X. doi: 10.1016/j.leukres.2015.08.007. PubMed |
One reporter for in-cell activity profiling of majority of protein kinase oncogenes.
Gudernova I, Foldynova-Trantirkova S, Ghannamova BE, Fafilek B, Varecha M, Balek L, Hruba E, Jonatova L, Jelinkova I, Kunova Bosakova M, Trantirek L, Mayer J, Krejci P.
Elife. 2017 Feb 15;6. pii: e21536. doi: 10.7554/eLife.21536.
PubMed
Associated Plasmids |
| Taxodione induces apoptosis in BCR-ABL-positive cells through ROS generation. Uchihara Y, Tago K, Taguchi H, Narukawa Y, Kiuchi F, Tamura H, Funakoshi-Tago M. Biochem Pharmacol. 2018 Aug;154:357-372. doi: 10.1016/j.bcp.2018.05.018. Epub 2018 Jun 1. PubMed |
| RUNX1 transactivates BCR-ABL1 expression in Philadelphia chromosome positive acute lymphoblastic leukemia. Masuda T, Maeda S, Shimada S, Sakuramoto N, Morita K, Koyama A, Suzuki K, Mitsuda Y, Matsuo H, Kubota H, Kato I, Tanaka K, Takita J, Hirata M, Kataoka TR, Nakahata T, Adachi S, Hirai H, Mizuta S, Naka K, Imai Y, Kimura S, Sugiyama H, Kamikubo Y. Cancer Sci. 2022 Feb;113(2):529-539. doi: 10.1111/cas.15239. Epub 2021 Dec 28. PubMed |
| FL118 Is a Potent Therapeutic Agent against Chronic Myeloid Leukemia Resistant to BCR-ABL Inhibitors through Targeting RNA Helicase DDX5. Takeda K, Ohta S, Nagao M, Kobayashi E, Tago K, Funakoshi-Tago M. Int J Mol Sci. 2024 Mar 26;25(7):3693. doi: 10.3390/ijms25073693. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.